Randomized clinical trial on the safety and the efficacy of Tegaderm for the prevention of hypernatremic dehydratation in preterm infants
Not Applicable
Recruiting
- Conditions
- hypernatremic dehydratation
- Registration Number
- JPRN-UMIN000010515
- Lead Sponsor
- Catholic University of Sacred Heart
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
major congenital malformations, chromosomal abnormalities, congenital infections, acute renal insufficiency
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of hypernatremia (plasma sodium > 145 mEq/L)
- Secondary Outcome Measures
Name Time Method Maximum weight loss, birth weight regain, hypotermia, hypertermia, intraventricular haemorrhage, sepsis, patent ductus arteriosus, systemic hypotension, bronchopulmonary dysplasia, necrotizing enterocolitis, retinopathy of prematurity, lenght of stay